VYOME HOLDINGS, INC. Operating Lease, Expense
VYOME HOLDINGS, INC. (HIND) reported Operating Lease, Expense of $24.00 thousand for the 6-month period ending 2025-06-30, per its 8-K filed 2025-09-02.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2025-09-02
- VYOME HOLDINGS, INC. operating lease, expense for the quarter ending 2021-03-31 was $100.00K, a 0.00% change year-over-year.
- VYOME HOLDINGS, INC. operating lease, expense for the quarter ending 2020-03-31 was $100.00K.
- VYOME HOLDINGS, INC. operating lease, expense for fiscal 2020 was $700.00K, a 16.67% increase from fiscal 2019.
- VYOME HOLDINGS, INC. operating lease, expense for fiscal 2019 was $600.00K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 12 month |
|---|---|---|---|
| 2025-06-30 | $24.00K 8-K · filed 2025-09-02 | ||
| 2024-06-30 | $19.90K 8-K · filed 2025-09-02 | ||
| 2021-03-31 | $100.00K 10-Q · filed 2021-05-12 | ||
| 2020-12-31 | $700.00K 10-K · filed 2021-03-12 | ||
| 2020-03-31 | $100.00K 10-Q · filed 2021-05-12 | ||
| 2019-12-31 | $600.00K 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |